IL4 and neoplasm: To this regard, IL-4 blockade in mouse tumor models was shown to reduce immunosuppressive cells, enhance anti-tumor cytotoxic T-cell activity and thus delay tumor progression, as well as synergistically improve immunotherapies (39).